Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Buchanan Communications


Contact Details:
107 Cheapside
London
Greater London
EC2V 6DT
United Kingdom
Tel:020 7466 5000
Fax:020 7466 5001
Email:
WWW:

www.buchanan.uk.com/




Loading...

Press Releases on Buchanan Communications:

BioPortfolio Logo
Oxford Biomedica Announces Appointment Of Chief Medical Officer 1st September, 2005 Oxford Biomedica
    Oxford Biomedica Announces Appointment Of Chief Medical Officer Oxford, UK: 7 September 2005 – Oxford BioMedica (LSE:OXB.L), the
Cobra and Auxilium Announce Extension of Agreement to Manufacture AA4500 1st August, 2005 Cobra
        Cobra and Auxilium Announce Extension of Agreement to Manufacture AA4500 for Auxilium Pharmaceuticals, Inc.
OXFORD BIOMEDICA SUCCESSFULLY COMPLETES STAGE ONE OF THE PHASE II TRIAL 1st August, 2005 Oxford Biomedica
    OXFORD BIOMEDICA SUCCESSFULLY COMPLETES STAGE ONE OF THE PHASE II TRIAL WITH METXIA IN PANCREATIC CANCER Oxford, UK: 1 August 2005
Oxford Biomedica Is Granted Key Lentivector® Patents In China 1st July, 2005 Oxford Biomedica
Oxford Biomedica Is Granted Key Lentivector® Patents In China Oxford, UK: 4 July 2005 – Oxford BioMedica (LSE: OXB), the leading gene therapy company, announced today that the Patent
Oxford Biomedica Presents Encouraging Innurex Preclinical Efficacy Data 1st June, 2005 Oxford Biomedica
Oxford Biomedica Presents Encouraging Innurex Preclinical Efficacy Data In Spinal Cord Injury - Presentation at the 8th Annual Meeting of the American Society of Gene Therapy, 1-5

BioNews Results for Buchanan Communications:

Minster Pharma. PLC : Interim Results
Investegate:  Nov 20 2009 7:44AM Matching: buchanan communications
Renovo - Adaprev Trial Commences: First Patient Treated
Pharma Live:  Nov 5 2009 11:15PM Matching: buchanan communications
Alliance Pharma - Trading Update
Therapeutics Daily:  Nov 5 2009 3:23PM Matching: buchanan communications
Proximagen Neuroscience plc (PRX.L) Signs to Acquire Cambridge Biotechnology from Biovitrum AB
BioSpace:  Oct 22 2009 3:40PM Matching: buchanan communications
Antisoma's AS1411 Gains US and EU Orphan Drug Status for Acute mMeloid Leukaemia
Pharma Live:  Oct 14 2009 3:19PM Matching: buchanan communications
Promote your company here: BioNewsCast - Press Release Distribution

View more Buchanan Communications news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 234 times since April 2007, the link to the organisation's website has been followed 46 times

Search for more companies in London

Search for more companies in Greater London



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Buchanan Communications

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.